New funding from CPRIT will help Rice advance cancer research on several fronts, from strengthening a core genetic engineering facility that serves researchers across Texas to supporting new studies in cancer immunotherapy, next-generation radiation therapy and ovarian cancer.
A team of Rice mechanical and electrical engineering students has developed an interactive, modular rehabilitation system designed to make stroke recovery more engaging, adaptable and effective for patients at home.
Rice, in collaboration with Baylor College of Medicine, will join BrainGate, a consortium of universities and academic medical centers working on creating brain-computer interface technologies.
Researchers developed a living bandage that accelerated healing across several wound types in animal models by continuously releasing therapeutic proteins at injury sites.
A team of Rice bioengineers has developed a new way to create highly realistic “mock” patient samples that could help accelerate the development of faster, more accessible cervical cancer screening tests for low-resource settings.
Rice researchers and collaborators at MD Anderson report results from a first-in-human trial evaluating a novel cell-based therapeutic platform in patients with advanced ovarian cancer.
Researchers at Rice and The University of Texas MD Anderson Cancer Center have developed a compact, artificial intelligence-powered imaging device that could transform how clinicians detect cancer.
Rice and Baylor College of Medicine have renewed their joint Superfund Research Program with a nearly $15 million, five-year grant from the National Institute of Environmental Health Sciences to advance detection, health research and cleanup technologies for a class of hazardous pollutants known as polycyclic aromatic hydrocarbons.
Multiple Rice-led student ventures earned top honors across categories at the Johns Hopkins Healthcare Design Competition. The founders built these winning businesses through Rice’s Liu Idea Lab for Innovation and Entrepreneurship (Lilie), underscoring the university’s growing leadership in health care innovation.
Three Rice students spent their spring break piloting a mobile health platform designed to support community health workers in underserved regions, including Guatemala, Kenya and Colombia.
Student innovators from across the globe gathered at Rice’s BioScience Research Collaborative to tackle some of the world’s most urgent health challenges.
Motif Neurotech, a company commercializing technology based on research at Rice, has received approval from the FDA to begin the first clinical trial of its therapeutic brain-computer interface for treatment of treatment-resistant depression.
Attacks on health care in conflict zones are occurring at unprecedented levels, according to Safeguarding Health Care in Conflict Coalition and Médecins Sans Frontières (Doctors Without Borders). Rice’s Baker Institute for Public Policy on April X hosted global leaders in the field and frontline medical professionals to discuss the erosion of protections for health care in conflict zones and explore solutions to ensure these critical rules are respected.